REFRACTORY ANGINA
Clinical trials for REFRACTORY ANGINA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY ANGINA trials appear
Sign up with your email to follow new studies for REFRACTORY ANGINA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could your own bone marrow cells ease stubborn chest pain?
Disease control OngoingThis study tests a treatment called CardiAMP, which uses a patient's own bone marrow cells to improve blood flow to the heart. It is for people with severe chest pain (angina) that does not get better with standard medicines or procedures. About 343 adults will be randomly assign…
Matched conditions: REFRACTORY ANGINA
Phase: NA • Sponsor: BioCardia, Inc. • Aim: Disease control
Last updated May 17, 2026 07:02 UTC
-
Heart drug trial halted before it began: no participants enrolled
Symptom relief TerminatedThis study was designed to test an experimental drug, IMB-1018972, in people with refractory angina—chest pain that doesn't improve with standard treatments. The goal was to see if the drug could safely help patients exercise longer and have fewer angina episodes. However, the tr…
Matched conditions: REFRACTORY ANGINA
Phase: PHASE2 • Sponsor: Imbria Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 11, 2026 20:50 UTC